Matrix Trust CO Bristol Myers Squibb CO Transaction History

Matrix Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$47.98 - $54.4 $44,141 - $50,048	-920 Reduced 4.05%	21,793 $1.18 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $31,124 - $37,139	-642 Reduced 2.75%	22,713 $1.17 Million
Q3 2023 Oct 30, 2023	BUY	$57.89 - $64.73 $9,378 - $10,486	162 Added 0.7%	23,355 $1.36 Million
Q2 2023 Jul 19, 2023	BUY	$63.71 - $70.74 $1.48 Million - $1.64 Million	23,193 New	23,193 $1.48 Million

2,404

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Matrix Trust CO, based on Form 13F filings with the SEC.

Stay updated on Matrix Trust CO with notifications on news.